Clinical Trials
5 trialsNCT00743262 2023-07-25
Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis
Atos Medical AB
Phase 1/2 Completed
NCT03254927 2023-04-03
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Celldex Therapeutics
Phase 2 Terminated
NCT01045057 2021-06-11
Clinical Feasibility of New Tracheoesophageal Puncture Set
Atos Medical AB
Phase NA Completed
NCT02437513 2017-08-24
NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration
ProTiP Medical
Terminated
NCT00661570 2017-03-10
Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis
Atos Medical AB
Phase NA Terminated